More than 30 from MIT named to Forbes 30 Under 30 lists
Forbes calls its 2019 30 Under 30 honorees “a collection of bold risk-takers who are putting a new twist on the old tools of the trade.”
Download RSS feed: News Articles / In the Media / Audio
Forbes calls its 2019 30 Under 30 honorees “a collection of bold risk-takers who are putting a new twist on the old tools of the trade.”
MIT spinoff is changing the way mosquito-borne illnesses are diagnosed and aims to influence how public health officials react to disease outbreaks.
Model predicts whether ER patients suffering from sepsis urgently need a change in therapy.
Smartphone app developed by Emily Lindemer PhD '17 uses social contacts and location information to give gentle reminders for staying engaged with recovery.
PhD student Richard Fineman is using wearable sensors to understand coordination and walking — and next-generation spacesuit design.
MIT researchers develop new tools to enable targeted delivery of drugs to deep brain structures through implanted microprobes.
Researchers generate an intestinal cell mimic that can be harnessed in studies of diseases such as inflammatory bowel disease.
“Therepi” device attaches directly to damaged heart, enabling delivery of medicine from a port under a patient’s skin to augment cardiac function.
Award honors top collegiate inventors in the United States.
Longtime biology professor and expert in hemoglobin synthesis was committed to the integration of biomedical research, education, and medical practice.
Award honors immigrants’ contributions to the United States.
Novel technology could allow researchers to develop and test new antimalaria drugs.
“REPAIR” system edits RNA, rather than DNA; has potential to treat diseases without permanently affecting the genome.
Former director of the MIT Clinical Research Center and professor in health sciences and technology contributed novel techniques and tools to cardiovascular research.
Findings support new strategy of continuous drug delivery by implantable device.